Ii4CI-PC by 5 min-Spleen accumulation of I'4Cl-PC increased administered liposomal PC was taken up by lung subcellular steadily, liver plateaued from 1-2 hr, and lung fell rapidly. The fractions, including lamellar bodies. uptake of liposomal [14CI-PC by lung and liver was dependent on the concentration of iv injected liposomal [14CI-PC. All lung subcellular fractions (lamellar bodies, mitochondria, and micro- Egg PC was isolated from lyophilized egg yolk and purified by can be taken up by lung lamellar bodies, it is possible that this PC aluminum oxide and silicic acid columns (1). Egg yolk PC purity will then be available for release to the alveolar surface. This Was examined by thin-layer chromatography (TLC) with a develpotentially might become a unique biochemical approach in the oping Solvent of chloroform:methanol:water (65:25:4). Purity of therapy of neonatal RDS. the radioactively labeled PC was also assured by TLC, and the fatty acid moieties of PC were confirmed by gas-liquid chromatography. A mixture of PC, dicetylphosphate, and cholesterol in PC, especially dipalmitoyl-PC, is quantitatively the major lipid a molar ratio of 7:2:1 was used for liposome preparation (21) . The component of alveolar lining surfactant (6, 16) , and is significantly lipids containing 10 pmole PC labeled with [l-'4C]-dipalmitoyllacking in neonatal RDS (5) . This most abundant disaturated-PC PC (10 pci) were dissolved in 1 ml chloroform, and the solvent is stored in the lamellar bodies of type I1 alveolar epithelial cells. was evaporated to dryness under nitrogen while the tube was It is then secreted to participate in forming a surface-active lining being rotated. The lipids that formed a thin film on the wall of the at the air-alveolar surface that stabilizes the lung and aids respi-tube were then suspended in 1 ml water; the tube was shaken by ration (5, 7). There is extensive research attempting to define the hand frequently for 1-2 hr at room temperature (20-25') . The mechanisms of PC biosynthesis and turnover in lung (26) .
MATERIALS AND METHODS

somes) took up [14CI-PC. Lamellar body ['4CI-PC was highest at
true specific radioactivity of liposomal PC was determined by Presently, the usual treatment approach for RDS is supportive analyzing the radioactivity and concentration of PC isolated from neonatal intensive care methods (S), in conjunction with assisted TLC. The radioactivity of PC recovered from TLC was measured ventilation and end positive pressure for hypoxia and ventilatory in 10 ml scintillation solution (3.3 g 3,s-diphenyloxazole in 400 ml failure. Antenatal maternal steroid administration to enhance fetal toluene, plus 200 ml ethylene glycol monoethyl ether) with a lung maturation and prevent neonatal RDS in the premature is Beckman CMP-100 liquid scintillation counter. The concentration now receiving considerable support and initial reports show prom-of PC isolated from TLC was determined by measuring its phosise (14, 18, 20, 22, 23) . Recent approaches have attempted to phorus content (3) in the presence of silica gel (24) . The specific deposit surfactant onto the alveolar surface by pharyngeal or radioactivity of liposomal PC was expressed as cpm per nmole tracheal instillation, using positive pressure ventilation of aerosol-PC. The average specific radioactivity from four preparations was ized synthetic PC, aerosolized PC extracted from lungs, and 1581 f 82 cpm/nmole PC (mean f SD). sonicated PC (10, 1 1, 17, 19) .
The size of hand shaken liposomes are about 1 pmeter in When phospholipids are suspended in an excess of aqueous diameter, but multilamellar liposomes do not always have a solution, they spontaneously form liposomes. Liposomes are mul-uniform size population (1, 25). However, the possible heterogetilamellar concentric bilayer vesicles with the lipid layers separated neity of the liposomes was not important at this time and was not by aqueous medium (25) . Liposomes have been extensively stud-determined. ied as models for biologic membranes (1) or as carrier vehicles for
In the pilot study, the stability of liposomes at 37' was tested.
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Liposomes were prepared in 0.3 M glucose and dialyzed against isotonic buffer of 0.075 M KC1 and 0.075 M NaCl at room temperature for 16 hr. The dialyzed liposomes were then incubated at 37". Glucose that escaped from liposome and that which was entrapped in liposomes was measured by the change in absorbance at 340 NM with a Beckman DUR spectrophotometer. The assay was camed out in a 10 mm. light path curvette containing the following reagents (4, 13): 0.28 ml 0. I M TrisHCl buffer (pH 8.0); 0.5 ml double strength isotonic solution (0.15 M KC1 and 0.15 M M NaCl); 0.1 ml magnesium acetate (0.02 M); 0.05 ml ATP (0.02 M); 0.05 ml NADP' (0.01 M); 5 p1 hexokinase (0.7 mg protein/ 0.1 ml) 5 pl glucose-6-phosphate dehydrogenase (0.3 mg protein/ 0.1 ml). All reagents were prepared in Tris buffer. The reaction was initiated by the addition of 5 pl of liposomes. After a stable change in absorbance was observed, 0.01 ml of 25% Triton X-100 solution in Tris buffer was added to the curvette to disrupt the liposome and release the remaining entrapped glucose. After 2 hr incubation at 37O, no significant amount of glucose had leaked out from liposomes.
ANIMAL INJECTION
Two-month-old rabbits were given an iv bolus injection in the right ear with 0.5 ml liposomes labeled with ['4C]-dipalmitoyl PC. After various times, the rabbits were killed and the tissues were removed and analyzed for ['4C]-PC. Lungs and livers were perfused intravascularly with cold saline to remove blood until the tissue was uniformly bloodless (white for lungs, pale brown for liver). Kidney, heart, spleen, and about 10 cm small intestine were also removed and rinsed with ice cold saline. Two g of each tissue sample was then homogenized in 6 ml cold 0.33M sucrose-0.0lM Tris HCI buffer (pH 7.4) in a Potter-Elvehjem homogenizer (clearance 0.005-0.007 inch) with six strokes at low speed. The homogenate was filtered through one layer of cheesecloth. Subcellular fractions of lung including lamellar bodies, mitochrondria, microsomes, and cytosol were isolated by the method of sucrose gradient described previously (24) and analyzed for [I4C]-PC.
ANALYSIS OF PHOSPHOLIPIDS AND PROTEIN
Lipids in the homogenate of each organ and subcellular fractions of lung were extracted by the method of Bligh and Dyer (2). PC was quantitatively isolated by TLC, and its radioactivity and concentration were measured as described previously.
The distribution of radioactivity in fatty acid moieties at the 1-and 2-positions of PC in liposomes, lung homogenate, and subcellular fractions was also analyzed in one experiment. PC was first separated by TLC with the developing solvent of chloroform: methanokwater (65:25:4). The TLC plate (20 x 20 cm) was then gently stained in iodine vapor for a few sec. The PC on the TLC plate was then hydrolyzed by 40 p1 Crotalus adamanteus venom phospholipase A2 (about 100 pg in 50 pl 0.05 M Tris HCI buffer containing 10 mM Ca2', pH 8.0) which was partially purified from Sephadex G-100 and DEAE-cellulose column chromatography (27) . After the PC spot on the silica gel was completely dry, the TLC plate was subjected to a second dimensional development in the same developing solvent. Radioactivities of fatty acid, PC, lysoPC, and the background corresponding to the same size of these spots between the solvent front and the origin were determined.
The protein concentration of the tissue homogenate and the subcellular fractions was determined by the method of Lowry et al. (15) ; bovine serum albumin was used as a standard. (Fig. 2) . This uptake vs. concentrationrelationship was 3.5-fold greater in lung than liver.
[I4]C-PC appeared in all lung subcellular fractions after liposo- (Fig. 3) .
The I4C radioactivity distribution in lipid fractions of lung and liver is shown in Table 1 . Lung radioactivity was still 95% [I4C]-PC, even after 2 hr, but 28% of liver radioactivity was present in free fatty acids, neutral lipid, or other unidentified lipids. At all times, lamellar body radioactivity was 99-100% as [I4C]-PC. The percent of PC radioactivity in the other lung subcellular fractions ranged from 90-95%, and no consistent change with time was noted.
DISCUSSION
Liposomes have recently been extensively used as camer vehicles for introducing membrane impermeable substances into cells. After entry into the target cells, the liposome is then broken down by intracellular lysosomal enzyme activity, thereby releasing the liposome-entrapped substance and allowing it to enter metabolic pathways of the cell. To date, few studies have been done on pulmonary uptake of liposomes (25) and there has been no study of the delivery of lipsomes to lung subcellular organelles.
The authors demonstrated that iv administered liposomal PC could be taken up by lung lamellar body. Lung, on a per mg protein basis, was as active as liver and spleen in takin ?4 liposomal [I4C]-PC. However, the kinetics of the liposomal [ C]-PC uptake and accumulation by lung was significantly different from that of other organs. Studies by others have shown that liver and spleen readily take up liposomes (25) . apparently because of their active reticuloendothelial systems. Hence, the injections of liposomal [14C]-PC here were given in the ear vein. That approach was chosen to insure that the liposomes would initially be distributed to the pulmonary circulation before being circulated through the portal, hepatic, and splenic vasculature, with a subsequent loss of significant amounts of material.
The disappearance of radioactivity from lung, after the initial rapid uptake, is not understood. (Table 1) . Another possible explanation for the disappearance of lung [I4C]-PC with time could be that it was being secreted onto the airway surface, migrating to upper airways, and was subsequently not included in lung homogenization. Preliminary tracheal wash experiments suggest this might be occumng, but more work is needed to prove the point.
Lung uptake of liposomal-PC appears active and valid by several criteria. The uptake was concentration dependent (Fig. 2) . Intracellular distribution of the accumulated liposomal [I4C]-PC into all subcellular fractions was demonstrated (Fig. 3) . The method used here for subcellular fractionation contains minimum cross contamination of the subcellular particles (24) . Finally, an in vitro experiment suggests that nonspecific adsorption of liposoma1 [I4C]-PC could only account for 10-25% of the [I4C]-PC in subcellular fractions. It might be possible that liposomes are "sticking" to the vascular bed of the lung and are not really being incorporated into cells. However, as just mentioned, the authors have checked for nonspecific adsorption in vitro and there is little. Additionally, in experiments including zero time, when blood is highest in liposomal [14C]-PC, the lung [I4C]-PC was much lower than the 5 min values, which again supyorts active lung uptake.
The possibility exists that liposomal [ 4C]-PC is degraded and the free fatty acids reincorporated into lung PC during this experiment. However, when lung PC isolated from these experiments was subjected to hydrolysis with snake venom phospholipase Az, the ratio of [14C]-fatty acids (free fatty acid:fatty acid in the IysoPC) was near unity for each time period. Although this does not absolutely rule out some hydrolysis and resynthesis during the experiment, this possibility is unlikely.
In summary, liposomal [14C]-PC injected into the ear vein of 2-month-old rabbits is rapid1 and actively taken up by lung. A Y significant amount of that [ 4C]-PC appears in the lamellar body fraction. The radioactivity in lamellar bodies disappears with time, but remains predominantly [14C]-PC for at least 2 hr. The rapid disappearance of [14C]-PC from lung in these experiments is not understood. IV injection of liposomal-PC to deliver PC to lung lamellar bodies as described here needs to be compared with other methods, such as using precursor incorporation or other PC solubilization and suspension methods. These questions require further investigation. 
